This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index added 4.13 to 92.47, while the CSE Composite Index lost 2.97 to 515.13. Canadian cannabis grower Tilray Inc. (TLRY) added $1.10 to $9.23 on 9.68 million shares, after releasing its financials for the fiscal second quarter ended Nov. 30. The stock spent the last week and half falling from over $10 (and is down from $16 since November), suggesting that investors did not have high hopes for the financials. Today's verdict was: mixed at best.

Tilray did not see it that way, of course. "Our second quarter performance reflects notable success," cheered chairman and chief executive officer Irwin Simon, patting the company on the back for having "increase[d] sales and maintain[ed] profitability." The word "profitable" also featured prominently in the headline. A list of highlights at the top proudly displayed net income of $6-million (U.S.) -- actually $5.7-million (U.S.), but still a rare appearance on the positive side of the ledger -- on revenue of $155-million (U.S.), with adjusted EBITDA of $13.8-million (U.S.).

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS